BDSX vs CUBE · rev $71.3M vs P/E 25, rev $1.07B
Biodesix Inc (BDSX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Biodesix Inc (BDSX) is a diagnostics & research company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BDSX revenue for 2024-12-31 was $71.3M. Net income was -$42.9M. Revenue was up 45.3% from 2023-12-31 to 2024-12-31. BDSX currently screens at market cap $157.6M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BDSX currently screens at market cap $157.6M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BDSX and CUBE stock pages for the full models.
Not investment advice.